These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


155 related items for PubMed ID: 34080023

  • 1. lncRNA TUG1 regulates angiogenesis via the miR‑204‑5p/JAK2/STAT3 axis in hepatoblastoma.
    Yuan MX, Ji CY, Gao HQ, Sheng XY, Xie WX, Yin Q.
    Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34080023
    [Abstract] [Full Text] [Related]

  • 2. Targeting long non-coding RNA-TUG1 inhibits tumor growth and angiogenesis in hepatoblastoma.
    Dong R, Liu GB, Liu BH, Chen G, Li K, Zheng S, Dong KR.
    Cell Death Dis; 2016 Jun 30; 7(6):e2278. PubMed ID: 27362796
    [Abstract] [Full Text] [Related]

  • 3. LncRNA TUG1 interacting with miR-144 contributes to proliferation, migration and tumorigenesis through activating the JAK2/STAT3 pathway in hepatocellular carcinoma.
    Lv J, Kong Y, Gao Z, Liu Y, Zhu P, Yu Z.
    Int J Biochem Cell Biol; 2018 Aug 30; 101():19-28. PubMed ID: 29791864
    [Abstract] [Full Text] [Related]

  • 4. Long noncoding TUG1 promotes angiogenesis of HUVECs in PE via regulating the miR-29a-3p/VEGFA and Ang2/Tie2 pathways.
    Liu Z, Guo N, Zhang XJ.
    Microvasc Res; 2022 Jan 30; 139():104231. PubMed ID: 34352236
    [Abstract] [Full Text] [Related]

  • 5. Long Non-Coding RNA CRNDE Regulates Angiogenesis in Hepatoblastoma by Targeting the MiR-203/VEGFA Axis.
    Chen LJ, Yuan MX, Ji CY, Zhang YB, Peng YM, Zhang T, Gao HQ, Sheng XY, Liu ZY, Xie WX, Yin Q.
    Pathobiology; 2020 Jan 30; 87(3):161-170. PubMed ID: 32182608
    [Abstract] [Full Text] [Related]

  • 6. Knockdown of lncRNA TUG1 suppresses corneal angiogenesis through regulating miR-505-3p/VEGFA.
    Liu S, Gao J, Chen J.
    Microvasc Res; 2021 Nov 30; 138():104233. PubMed ID: 34411571
    [Abstract] [Full Text] [Related]

  • 7. Long non-coding RNA taurine upregulated 1 enhances tumor-induced angiogenesis through inhibiting microRNA-299 in human glioblastoma.
    Cai H, Liu X, Zheng J, Xue Y, Ma J, Li Z, Xi Z, Li Z, Bao M, Liu Y.
    Oncogene; 2017 Jan 19; 36(3):318-331. PubMed ID: 27345398
    [Abstract] [Full Text] [Related]

  • 8. Long noncoding RNA TUG1 upregulates VEGFA to enhance malignant behaviors in stomach adenocarcinoma by sponging miR-29c-3p.
    Jin Y, Cao J, Hu X, Cheng H.
    J Clin Lab Anal; 2021 Dec 19; 35(12):e24106. PubMed ID: 34762771
    [Abstract] [Full Text] [Related]

  • 9. Melanoma cell-secreted exosomal miR-155-5p induce proangiogenic switch of cancer-associated fibroblasts via SOCS1/JAK2/STAT3 signaling pathway.
    Zhou X, Yan T, Huang C, Xu Z, Wang L, Jiang E, Wang H, Chen Y, Liu K, Shao Z, Shang Z.
    J Exp Clin Cancer Res; 2018 Oct 03; 37(1):242. PubMed ID: 30285793
    [Abstract] [Full Text] [Related]

  • 10. MicroRNA-204 deregulation in lung adenocarcinoma controls the biological behaviors of endothelial cells potentially by modulating Janus kinase 2-signal transducer and activator of transcription 3 pathway.
    Liu X, Gao X, Zhang W, Zhu T, Bi W, Zhang Y.
    IUBMB Life; 2018 Jan 03; 70(1):81-91. PubMed ID: 29281186
    [Abstract] [Full Text] [Related]

  • 11. LncRNA CCAT2 promotes angiogenesis in glioma through activation of VEGFA signalling by sponging miR-424.
    Sun SL, Shu YG, Tao MY.
    Mol Cell Biochem; 2020 May 03; 468(1-2):69-82. PubMed ID: 32236863
    [Abstract] [Full Text] [Related]

  • 12. LncRNA PVT1 promotes angiogenesis via activating the STAT3/VEGFA axis in gastric cancer.
    Zhao J, Du P, Cui P, Qin Y, Hu C, Wu J, Zhou Z, Zhang W, Qin L, Huang G.
    Oncogene; 2018 Jul 03; 37(30):4094-4109. PubMed ID: 29706652
    [Abstract] [Full Text] [Related]

  • 13. Knockdown of lncRNA ANRIL suppresses the production of inflammatory cytokines and mucin 5AC in nasal epithelial cells via the miR-15a-5p/JAK2 axis.
    Liu HW, Hu ZL, Li H, Tan QF, Tong J, Zhang YQ.
    Mol Med Rep; 2021 Feb 03; 23(2):. PubMed ID: 33325534
    [Abstract] [Full Text] [Related]

  • 14. miR-204 inhibits angiogenesis and promotes sensitivity to cetuximab in head and neck squamous cell carcinoma cells by blocking JAK2-STAT3 signaling.
    Wu Q, Zhao Y, Wang P.
    Biomed Pharmacother; 2018 Mar 03; 99():278-285. PubMed ID: 29353201
    [Abstract] [Full Text] [Related]

  • 15. LncRNA TUG1 promotes cell proliferation and suppresses apoptosis in osteosarcoma by regulating miR-212-3p/FOXA1 axis.
    Xie C, Chen B, Wu B, Guo J, Cao Y.
    Biomed Pharmacother; 2018 Jan 03; 97():1645-1653. PubMed ID: 29793327
    [Abstract] [Full Text] [Related]

  • 16. Down-regulating NEAT1 inhibited the viability and vasculogenic mimicry formation of sinonasal squamous cell carcinoma cells via miR-195-5p/VEGFA axis.
    Lu H, Kang F.
    Biosci Rep; 2020 Nov 27; 40(11):. PubMed ID: 33146672
    [Abstract] [Full Text] [Related]

  • 17. LncRNA 00152 promotes the development of hepatocellular carcinoma by activating JAK2/STAT3 pathway.
    Li SJ, Sui MH, Sun ZX, Zhang WW.
    Eur Rev Med Pharmacol Sci; 2019 Feb 27; 23(3):1038-1046. PubMed ID: 30779070
    [Abstract] [Full Text] [Related]

  • 18. Exosomal lncRNA HOTAIR Promotes the Progression and Angiogenesis of Endometriosis via the miR-761/HDAC1 Axis and Activation of STAT3-Mediated Inflammation.
    Zhang L, Yu Z, Qu Q, Li X, Lu X, Zhang H.
    Int J Nanomedicine; 2022 Feb 27; 17():1155-1170. PubMed ID: 35321026
    [Abstract] [Full Text] [Related]

  • 19. lncRNA TUG1 modulates proliferation, apoptosis, invasion, and angiogenesis via targeting miR-29b in trophoblast cells.
    Li Q, Zhang J, Su DM, Guan LN, Mu WH, Yu M, Ma X, Yang RJ.
    Hum Genomics; 2019 Sep 13; 13(1):50. PubMed ID: 31519209
    [Abstract] [Full Text] [Related]

  • 20. Long Noncoding RNA Taurine-Upregulated Gene1 (TUG1) Promotes Tumor Growth and Metastasis Through TUG1/Mir-129-5p/Astrocyte-Elevated Gene-1 (AEG-1) Axis in Malignant Melanoma.
    Long J, Menggen Q, Wuren Q, Shi Q, Pi X.
    Med Sci Monit; 2018 Mar 15; 24():1547-1559. PubMed ID: 29543785
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.